Press Release
| Particulars | Q1FY24 | Q1FY23 | % YoY | Q4FY23 |
| Total Income | 570.24 | 570.16 | - | 595.93 |
| EBITDA | 79.92 | 61.17 | 30.6 % | 104.51 |
| EBITDA Margin (%) | 14.0% | 10.7% | 330 bps | 17.5 % |
| PAT | 46.21 | 34.89 | 32.4% | 65.27 |
| PAT Margin (%) | 8.1% | 6.1% | 200 bps | 11.0% |
Commenting on the performance, Mr Vikas Gupta, Joint Managing Director, said “We are pleased to report sustainable performance during the 1st quarter of FY24, tackling present challenges while positioning ourselves for forthcoming opportunities. We are hopeful for increased presence in regulatory market as the Company got CEP for paracetamol. Additionally, with the commencement of Acetic Anhydride plant, focus on improved efficiencies, product mix and timely execution we are hopeful to generate strong cash flow”.
Chemical Market has been in the industry since almost 40 years. We owe our success to you and since the last few years things have been crazy for the world at large. The editorial independence has never been more important.
Our articles and press releases come from reliable sources and we keep delivering high impact trustworthy news, reviews and technical articles and reports free from commercial or political influence.
We believe everyone deserves equal access to accurate news and there are many news aggregator sites but we don't participate in those as they have a very broad criteria where not all news articles sites can participate and not all of them are true articles written for the purpose of knowledge but mostly are commercialized. We bring you news and information in the chemical industry and provide vital information to make decisions based on fact and not fiction.
Subscribe our magazine for as little as Rs.50 a month (Rs. 600/yr) or $1 a month ($11.99/yr)
